Iradimed (IRMD) Preferred Shares (2013 - 2014)

Iradimed's (IRMD) quarterly Preferred Shares came in at $140.0 in Q2 2014, little changed on a QoQ basis from $140.0 in Q4 2013.

Iradimed (IRMD) Preferred Shares (2013 - 2014) Analysis & Trends

Iradimed (IRMD) has 2 years of Preferred Shares data on file, last reported at $140.0 in Q2 2014.

On a quarterly basis, Preferred Shares changed N/A year-over-year to $140.0 in Q2 2014; TTM through Jun 2014 was $140.0, a N/A change from a year earlier, with the FY2013 full-year figure at $140.0, changed N/A from the prior year.
Preferred Shares for Q2 2014 stood at $140.0, roughly flat from $140.0 in the prior quarter.
Over the last five years, Preferred Shares for IRMD reached as high as $140.0 in Q4 2013 and fell as low as $140.0 in Q4 2013.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	-
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	-
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	-
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	-
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	-
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	-
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	-
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	-
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	-
10	Iradimed	1.20 Bn	1.14 Bn	16.81 Mn	-

Historic Data

Download Data

Date	Value
Jun 30, 2014	140.00
Dec 31, 2013	140.00